Document is current
Any future updates will be listed below
-
Authors
Przepiórska-Drońska, Karolina https://orcid.org/0000-0003-4114-1283
Wnuk, Agnieszka https://orcid.org/0000-0003-3620-3902
Pietrzak-Wawrzyńska, Bernadeta Angelika https://orcid.org/0000-0002-8000-1120
Łach, Andrzej https://orcid.org/0000-0003-4065-7923
Biernat, Weronika https://orcid.org/0000-0001-9834-9232
Wójtowicz, Anna Katarzyna https://orcid.org/0000-0002-5819-6654
Kajta, Małgorzata https://orcid.org/0000-0003-0616-7031
-
Funding
Funding for this research was provided by:
National Science Centre of Poland (2018/31/B/NZ7/01815)
the statutory fund of the Maj Institute of Pharmacology, Polish Academy of Sciences in Krakow, Poland
- License Information
-
More Information
Article History
Received: 22 December 2023
Accepted: 8 June 2024
First Online: 1 July 2024
Declarations
:
: The experiments were conducted in compliance with European Union Legislation (Directive 2010/63/EU, amended by Regulation (EU) 2019/1010) and approved by the Bioethics Commission as being compliant with Polish Law (21 August 1997). The study was conducted according to the guidelines of the Declaration of Helsinki, and did not require the approval of the Ethics Committee of Maj Institute of Pharmacology PAS since the research was conducted on primary neuronal cells.
: Non-applicable.
: Non-applicable.
: The authors have no relevant financial or non-financial interests to disclose.
